1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Virology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Virology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Virology Market Regional Analysis
6.2 Middle East and Africa Virology Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Virology Market Forecast Analysis
7. Middle East and Africa Virology Market Analysis – by Type
7.1 Diagnostic Test
- 7.1.1 Overview
- 7.1.2 Diagnostic Test: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Viral Infection Controlling Techniques
- 7.2.1 Overview
- 7.2.2 Viral Infection Controlling Techniques: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Antiviral Therapeutics
- 7.3.1 Overview
- 7.3.2 Antiviral Therapeutics: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Interferons
- 7.4.1 Overview
- 7.4.2 Interferons: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East and Africa Virology Market Analysis – by Application
8.1 Skin and Soft Tissue Infections
- 8.1.1 Overview
- 8.1.2 Skin and Soft Tissue Infections: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Respiratory Tract Infections
- 8.2.1 Overview
- 8.2.2 Respiratory Tract Infections: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 GI Tract Infections
- 8.3.1 Overview
- 8.3.2 GI Tract Infections: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Sexually Transmitted Diseases
- 8.4.1 Overview
- 8.4.2 Sexually Transmitted Diseases: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Urinary Tract Infection
- 8.5.1 Overview
- 8.5.2 Urinary Tract Infection: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East and Africa Virology Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical and Biotechnological Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biotechnological Companies: Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Research and Academic Institutes
- 9.4.1 Overview
- 9.4.2 Research and Academic Institutes : Middle East and Africa Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Middle East and Africa Virology Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East and Africa Virology Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Middle East and Africa Virology Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East and Africa Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa Virology Market Breakdown, by Type
- 10.2.1.1.2 South Africa: Middle East and Africa Virology Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East and Africa Virology Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia:
Middle East and Africa Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Virology Market Breakdown, by Type
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Virology Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Virology Market Breakdown, by End User
- 10.2.1.3 UAE:
Middle East and Africa Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa Virology Market Breakdown, by Type
- 10.2.1.3.2 UAE: Middle East and Africa Virology Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East and Africa Virology Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Virology Market Breakdown, by Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Virology Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Virology Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AbbVie Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Gilead Sciences, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GlaxoSmithKline Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Illumina, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 QIAGEN
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations